Clinical Trials Directory

Trials / Completed

CompletedNCT04783207

Effects of Mitopure (Urolithin A) on Skeletal Muscle Function, Iron Metabolism and Endurance Performance

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Mitopure (Urolithin A) on Skeletal Muscle Function, Iron Metabolism and Endurance Performance in Athletes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Amazentis SA · Industry
Sex
Male
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This is a randomized, double-blind, placebo-controlled study enrolling 36 (16 Elite and 20 Sub-Elite trained endurance runners (18 placebo and 18 Mitopure intervention) who are 18-40 years of age. Mitopure or Placebo supplement, will be given as a daily oral dose for 4-weeks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMitopureSoftgel containing 250 mg of Urolithin A (Mitopure) with excipients. 4 soft-gels to be taken daily
DIETARY_SUPPLEMENTPlaceboSoftgel containing only excipients. 4 soft-gels to be taken daily

Timeline

Start date
2021-04-21
Primary completion
2022-05-30
Completion
2023-08-30
First posted
2021-03-05
Last updated
2023-08-31

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT04783207. Inclusion in this directory is not an endorsement.

Effects of Mitopure (Urolithin A) on Skeletal Muscle Function, Iron Metabolism and Endurance Performance (NCT04783207) · Clinical Trials Directory